The aim of the present study was to investigate the levels of ascitic NGAL in patients with decompensated liver cirrhosis‐related SBP, and whether values of ascitic NGAL can be used to screen for SBP, for measuring the disease dynamics, and for predicting the prognosis of SBP patients. The gene discussed is LCN2; the disease is cirrhosis of liver.